Search Results 951-960 of 21349 for anti-TNF drugs

  1. Thalidomide (Oral Route) Precautions - Mayo Clinic

    Females who can get pregnant must have a negative pregnancy test before starting treatment with this medicine. Pregnancy tests may be done weekly for the first ...

  2. Atropine, Hyoscyamine, Methenamine, Methylene Blue, Phenyl Salicylate, And Benzoic Acid (Oral Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  3. Flurbiprofen (Oral Route) Precautions - Mayo Clinic

    Although this is rare, it may occur often in patients who are allergic to aspirin or other nonsteroidal anti-inflammatory drugs. Anaphylaxis requires ...

  4. Botulism Antitoxin (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  5. Decongestant And Analgesic Combinations (Oral Route) Before Using - Mayo Clinic

    Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care ...

  6. Ceftriaxone (Injection Route) Description and Brand Names - Mayo Clinic

    Ceftriaxone belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth. However, this ...

  7. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...

  8. Acarbose (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  9. Guidance on patients at risk of drug-induced sudden cardiac death from off-label COVID-19 treatments - Mayo Clinic News Network

    Some of the medications being used to treat COVID-19 are known to cause drug-induced prolongation of the QTc of some people. The QTc is an indicator of the ...

  10. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

    ... TNF] agents) within 4 weeks prior to cycle 1, day ... drugs); replacement therapy ... A stable regimen of highly active anti-retroviral therapy (HAART) ...